Cho et al. showed that a small molecule named PT2399 (Fig. 9A) directly binds and inhibits HIF2α, which causes tumor regression in an on-target fashion in preclinical mouse models established from human primary and metastatic pVHL-defective ccRCC [78]. The gene discussed is VHL; the disease is neoplasm.